Literature DB >> 23319593

Hydralazine and organic nitrates restore impaired excitation-contraction coupling by reducing calcium leak associated with nitroso-redox imbalance.

Raul A Dulce1, Omer Yiginer, Daniel R Gonzalez, Garrett Goss, Ning Feng, Meizi Zheng, Joshua M Hare.   

Abstract

Although the combined use of hydralazine and isosorbide dinitrate confers important clinical benefits in patients with heart failure, the underlying mechanism of action is still controversial. We used two models of nitroso-redox imbalance, neuronal NO synthase-deficient (NOS1(-/-)) mice and spontaneously hypertensive heart failure rats, to test the hypothesis that hydralazine (HYD) alone or in combination with nitroglycerin (NTG) or isosorbide dinitrate restores Ca(2+) cycling and contractile performance and controls superoxide production in isolated cardiomyocytes. The response to increased pacing frequency was depressed in NOS1(-/-) compared with wild type myocytes. Both sarcomere length shortening and intracellular Ca(2+) transient (Δ[Ca(2+)]i) responses in NOS1(-/-) cardiomyocytes were augmented by HYD in a dose-dependent manner. NTG alone did not affect myocyte shortening but reduced Δ[Ca(2+)]i across the range of pacing frequencies and increased myofilament Ca(2+) sensitivity thereby enhancing contractile efficiency. Similar results were seen in failing myocytes from the heart failure rat model. HYD alone or in combination with NTG reduced sarcoplasmic reticulum (SR) leak, improved SR Ca(2+) reuptake, and restored SR Ca(2+) content. HYD and NTG at low concentrations (1 μm), scavenged superoxide in isolated cardiomyocytes, whereas in cardiac homogenates, NTG inhibited xanthine oxidoreductase activity and scavenged NADPH oxidase-dependent superoxide more efficiently than HYD. Together, these results revealed that by reducing SR Ca(2+) leak, HYD improves Ca(2+) cycling and contractility impaired by nitroso-redox imbalance, and NTG enhanced contractile efficiency, restoring cardiac excitation-contraction coupling.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23319593      PMCID: PMC3585085          DOI: 10.1074/jbc.M112.412130

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  58 in total

1.  Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.

Authors:  Anne L Taylor; Susan Ziesche; Clyde Yancy; Peter Carson; Ralph D'Agostino; Keith Ferdinand; Malcolm Taylor; Kirkwood Adams; Michael Sabolinski; Manuel Worcel; Jay N Cohn
Journal:  N Engl J Med       Date:  2004-11-08       Impact factor: 91.245

2.  Xanthine oxidase inhibition ameliorates cardiovascular dysfunction in dogs with pacing-induced heart failure.

Authors:  Luciano C Amado; Anastasios P Saliaris; Shubha V Y Raju; Stephanie Lehrke; Marcus St John; Jinsheng Xie; Garrick Stewart; Torin Fitton; Khalid M Minhas; Jeff Brawn; Joshua M Hare
Journal:  J Mol Cell Cardiol       Date:  2005-09       Impact factor: 5.000

3.  Deficiency of neuronal nitric oxide synthase increases mortality and cardiac remodeling after myocardial infarction: role of nitroso-redox equilibrium.

Authors:  Roberto M Saraiva; Khalid M Minhas; Shubha V Y Raju; Lili A Barouch; Eleanor Pitz; Karl H Schuleri; Koenraad Vandegaer; Dechun Li; Joshua M Hare
Journal:  Circulation       Date:  2005-11-21       Impact factor: 29.690

4.  Peroxynitrite and myocardial contractility: in vivo versus in vitro effects.

Authors:  Tatsuo Katori; Sonia Donzelli; Carlo G Tocchetti; Katrina M Miranda; Gianfrancesco Cormaci; Douglas D Thomas; Elizabeth A Ketner; Myung Jae Lee; Daniele Mancardi; David A Wink; David A Kass; Nazareno Paolocci
Journal:  Free Radic Biol Med       Date:  2006-09-05       Impact factor: 7.376

5.  Increased phospholamban phosphorylation limits the force-frequency response in the MLP-/- mouse with heart failure.

Authors:  Gudrun Antoons; Peter Vangheluwe; Paul G A Volders; Virginie Bito; Patricia Holemans; Marcello Ceci; Frank Wuytack; Pico Caroni; Kanigula Mubagwa; Karin R Sipido
Journal:  J Mol Cell Cardiol       Date:  2006-01-20       Impact factor: 5.000

6.  Reduced neuronal nitric oxide synthase expression contributes to cardiac oxidative stress and nitroso-redox imbalance in ob/ob mice.

Authors:  Roberto M Saraiva; Khalid M Minhas; Meizi Zheng; Eleanor Pitz; Adriana Treuer; Daniel Gonzalez; Karl H Schuleri; Koenraad M Vandegaer; Lili A Barouch; Joshua M Hare
Journal:  Nitric Oxide       Date:  2006-12-21       Impact factor: 4.427

Review 7.  The oxidative stress concept of nitrate tolerance and the antioxidant properties of hydralazine.

Authors:  Andreas Daiber; Alexander Mülsch; Ulrich Hink; Hanke Mollnau; Ascan Warnholtz; Matthias Oelze; Thomas Münzel
Journal:  Am J Cardiol       Date:  2005-08-08       Impact factor: 2.778

8.  Uric acid and endothelial dysfunction in essential hypertension.

Authors:  Carmine Zoccali; Raffaele Maio; Francesca Mallamaci; Giorgio Sesti; Francesco Perticone
Journal:  J Am Soc Nephrol       Date:  2006-04-12       Impact factor: 10.121

9.  Frequency-dependent myofilament Ca2+ desensitization in failing rat myocardium.

Authors:  Regis R Lamberts; Nazha Hamdani; Tenoedj W Soekhoe; Nicky M Boontje; Ruud Zaremba; Lori A Walker; Pieter P de Tombe; Jolanda van der Velden; Ger J M Stienen
Journal:  J Physiol       Date:  2007-05-03       Impact factor: 5.182

10.  Deficient ryanodine receptor S-nitrosylation increases sarcoplasmic reticulum calcium leak and arrhythmogenesis in cardiomyocytes.

Authors:  Daniel R Gonzalez; Farideh Beigi; Adriana V Treuer; Joshua M Hare
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-12       Impact factor: 11.205

View more
  20 in total

Review 1.  Abnormal Ca(2+) cycling in failing ventricular myocytes: role of NOS1-mediated nitroso-redox balance.

Authors:  Mark T Ziolo; Steven R Houser
Journal:  Antioxid Redox Signal       Date:  2014-08-07       Impact factor: 8.401

Review 2.  Pathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implications.

Authors:  Thomas Münzel; Tommaso Gori; John F Keaney; Christoph Maack; Andreas Daiber
Journal:  Eur Heart J       Date:  2015-07-04       Impact factor: 29.983

3.  Mesenchymal stem cells suppress cardiac alternans by activation of PI3K mediated nitroso-redox pathway.

Authors:  Prasongchai Sattayaprasert; Drew M Nassal; Xiaoping Wan; Isabelle Deschenes; Kenneth R Laurita
Journal:  J Mol Cell Cardiol       Date:  2016-05-26       Impact factor: 5.000

4.  S-Nitrosylation of Sarcomeric Proteins Depresses Myofilament Ca2+)Sensitivity in Intact Cardiomyocytes.

Authors:  Cícero Figueiredo-Freitas; Raul A Dulce; Matthew W Foster; Jingsheng Liang; Aline M S Yamashita; Frederico L Lima-Rosa; J Will Thompson; M Arthur Moseley; Joshua M Hare; Leonardo Nogueira; Martha M Sorenson; José Renato Pinto
Journal:  Antioxid Redox Signal       Date:  2015-11-01       Impact factor: 8.401

5.  Obligatory role of neuronal nitric oxide synthase in the heart's antioxidant adaptation with exercise.

Authors:  Steve R Roof; Hsiang-Ting Ho; Sean C Little; Joseph E Ostler; Elizabeth A Brundage; Muthu Periasamy; Frederick A Villamena; Sandor Györke; Brandon J Biesiadecki; Christophe Heymes; Steven R Houser; Jonathan P Davis; Mark T Ziolo
Journal:  J Mol Cell Cardiol       Date:  2015-01-14       Impact factor: 5.000

Review 6.  Impact of Oxidative Stress on the Heart and Vasculature: Part 2 of a 3-Part Series.

Authors:  Thomas Münzel; Giovanni G Camici; Christoph Maack; Nicole R Bonetti; Valentin Fuster; Jason C Kovacic
Journal:  J Am Coll Cardiol       Date:  2017-07-11       Impact factor: 24.094

7.  Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study.

Authors:  Michael M Givertz; Kevin J Anstrom; Margaret M Redfield; Anita Deswal; Haissam Haddad; Javed Butler; W H Wilson Tang; Mark E Dunlap; Martin M LeWinter; Douglas L Mann; G Michael Felker; Christopher M O'Connor; Steven R Goldsmith; Elizabeth O Ofili; Mitchell T Saltzberg; Kenneth B Margulies; Thomas P Cappola; Marvin A Konstam; Marc J Semigran; Steven E McNulty; Kerry L Lee; Monica R Shah; Adrian F Hernandez
Journal:  Circulation       Date:  2015-04-14       Impact factor: 29.690

8.  Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.

Authors:  Robert M Carey; David A Calhoun; George L Bakris; Robert D Brook; Stacie L Daugherty; Cheryl R Dennison-Himmelfarb; Brent M Egan; John M Flack; Samuel S Gidding; Eric Judd; Daniel T Lackland; Cheryl L Laffer; Christopher Newton-Cheh; Steven M Smith; Sandra J Taler; Stephen C Textor; Tanya N Turan; William B White
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

9.  NADPH oxidase-2 inhibition restores contractility and intracellular calcium handling and reduces arrhythmogenicity in dystrophic cardiomyopathy.

Authors:  Daniel R Gonzalez; Adriana V Treuer; Guillaume Lamirault; Vera Mayo; Yenong Cao; Raul A Dulce; Joshua M Hare
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-07-11       Impact factor: 4.733

10.  Long term ablation of protein kinase A (PKA)-mediated cardiac troponin I phosphorylation leads to excitation-contraction uncoupling and diastolic dysfunction in a knock-in mouse model of hypertrophic cardiomyopathy.

Authors:  David Dweck; Marcos A Sanchez-Gonzalez; Audrey N Chang; Raul A Dulce; Crystal-Dawn Badger; Andrew P Koutnik; Edda L Ruiz; Brittany Griffin; Jingsheng Liang; Mohamed Kabbaj; Frank D Fincham; Joshua M Hare; J Michael Overton; Jose R Pinto
Journal:  J Biol Chem       Date:  2014-06-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.